Nakajima, Motowo

Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy.

Ishizuka, M., Abe, F., Sano, Y., Takahashi, K., Inoue, K., Nakajima, M., Kohda, T., Komatsu, N., Ogura, S.-I., & Tanaka, T. (2011) · International Immunopharmacology

Photodynamic Therapy Research StudiesPorphyrin Metabolism and Disorders

Cited by 255

The receptor for advanced glycation end‐products (RAGE) directly binds to ERK by a D‐domain‐like docking site

Ishihara, K., Tsutsumi, K., Kawane, S., Nakajima, M., & Kasaoka, T. (2003) · FEBS Letters

Advanced Glycation End Products researchProtein Kinase Regulation and GTPase Signaling

Cited by 201

Mechanistic study of PpIX accumulation using the JFCR39 cell panel revealed a role for dynamin 2-mediated exocytosis

Kitajima, Y., Ishii, T., Kohda, T., Ishizuka, M., Yamazaki, K., Nishimura, Y., Tanaka, T., Dan, S., & Nakajima, M. (2019) · Scientific Reports

Photodynamic Therapy Research StudiesNanoplatforms for cancer theranostics

Cited by 56